Pfizer's stock has fallen by more than 50% from its 2021 highs and faces some headwinds, but remains worth a deep dive for long-term investors.

Babies born prematurely can have a number of complications at birth, simply because they are brought into the world before ...

Since its launch, Rezdiffra has made steady commercial progress. In the third quarter, Madrigal's single approved product ...

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...